...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Role of nitric oxide on pressor mechanisms within the dorsomedial and rostral ventrolateral medulla in anaesthetized cats.
【24h】

Role of nitric oxide on pressor mechanisms within the dorsomedial and rostral ventrolateral medulla in anaesthetized cats.

机译:一氧化氮对麻醉猫的背部和延髓腹侧延髓内加压机制的作用。

获取原文
获取原文并翻译 | 示例

摘要

1. The role of nitric oxide (NO) in central cardiovascular regulation and the correlation between NO and glutamate-induced mechanisms is not clear. Microinjection of glutamate (3 nmol/30 nL) into dorsomedial medulla (DM) and rostral ventrolateral medulla (RVLM) increased arterial blood pressure (BP) and sympathetic vertebral nerve activity (VNA). Thus, in the present study, we examined the modulation by NO of glutamate-induced pressor responses in the DM and RVLM of cats. 2. Histochemical methods using nicotinamide adenine dinucleotide phosphate diaphorase (NADPHd) as a marker to stain neurons containing NO synthase (NOS), showed positive findings of NOS in both the DM and RVLM. 3. Microinjection of N(G)-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, into the DM or RVLM did not alter resting BP and VNA, but it did cause a dose-dependent attenuation of glutamate-induced pressor responses. Interestingly, the increase in NO levels that resulted from pretreatment with L-arginine (L-Arg) or sodium nitroprusside (SNP) did not alter resting BP and VNA, but still inhibited glutamate-induced pressor responses in the DM and RVLM in a dose-dependent manner. 4. We also examined whether NO modulated the pressor responses induced by activation of different excitatory amino acid receptors. N-Methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) were used. Consistent with the results from the initial glutamate studies, we observed that not only L-NAME, but also L-Arg and SNP attenuated pressor responses induced by NMDA and AMPA. No difference was found between the effects of NO on NMDA- and AMPA-induced pressor responses. 5. To investigate the possibility of a loss of agonist selectivity, the effects of D-2-amino-5-phosphonovalerate (D-AP5) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) on AMPA and NMDA responses in the DM were examined. The results showed that CNQX did not alter NMDA-induced pressor responses, while D-AP5 failed to alter AMPA-induced responses. 6. Our results suggest that activation of the glutamate-induced pressor mechanism is regulated by changes in NO levels in the DM and RVLM. This implies that NO may play a permissive role to allow operation of the glutamate-activation mechanism.
机译:一氧化氮(NO)在中枢心血管调节中的作用以及谷氨酸诱导的机制与NO之间的关系尚不清楚。将谷氨酸(3 nmol / 30 nL)微量注射到背部延髓(DM)和延髓腹侧延髓(RVLM)中会增加动脉血压(BP)和交感性椎神经活动(VNA)。因此,在本研究中,我们检查了猫的DM和RVLM中谷氨酸诱导的升压反应的NO调节。 2.使用烟酰胺腺嘌呤二核苷酸磷酸黄递酶(NADPHd)作为标记物染色含有NO合酶(NOS)的神经元的组织化学方法,在DM和RVLM中均显示出NOS的阳性发现。 3.将NOS抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME)微量注射到DM或RVLM中并不会改变静息BP和VNA,但确实会导致剂量依赖性的谷氨酸衰减诱导的升压反应。有趣的是,由L-精氨酸(L-Arg)或硝普钠(SNP)预处理导致的NO水平升高并未改变静息BP和VNA,但仍以一定剂量抑制了DM和RVLM中谷氨酸诱导的升压反应。依赖的方式。 4.我们还检查了NO是否调节了由不同的兴奋性氨基酸受体的激活引起的升压反应。使用了N-甲基-D-天冬氨酸(NMDA)和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)。与最初的谷氨酸研究结果一致,我们观察到不仅L-NAME,而且L-Arg和SNP减弱了NMDA和AMPA诱导的升压反应。 NO对NMDA和AMPA诱导的升压反应的影响之间没有发现差异。 5.研究激动剂选择性丧失的可能性,D-2-氨基-5-膦酸戊二酸酯(D-AP5)和6-氰基-7-硝基喹喔啉-2,3-二酮(CNQX)对AMPA和检查了DM中的NMDA应答。结果表明,CNQX不会改变NMDA诱导的升压反应,而D-AP5不能改变AMPA诱导的升压反应。 6.我们的结果表明,谷氨酸诱导的升压机制的激活受DM和RVLM中NO水平的变化调节。这意味着NO可能在允许谷氨酸激活机制运行中起宽松的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号